1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Sanara MedTech Inc.

Sanara MedTech Inc.

SMTI
Sanara MedTech Inc.US flagNASDAQ Capital Market
32.77
USD
-0.37
- -
301.09MMarket Cap

Total Valuation

Sanara MedTech Inc. carries a market capitalization of 301.09M, placing it among publicly traded companies globally. Its enterprise value stands at 249.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap301.09M
Enterprise Value249.97M

Share Statistics

Sanara MedTech Inc. currently has 9.19M shares outstanding.

Shares Outstanding9.19M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.85, and the price-to-book ratio stands at 27.30.

PE RatioN/A
PS Ratio1.85
PB Ratio27.30
P/TBV Ratio-16.77
P/FCF Ratio30.03
P/OCF Ratio35.72

Enterprise Valuation

On an enterprise value basis, Sanara MedTech Inc. trades at an EV/EBITDA multiple of 18.98 and an EV/FCF ratio of 17.67. The EV/Sales ratio of 2.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.36 provides insight into valuation relative to core operating earnings.

EV / Sales2.28
EV / EBITDA18.98
EV / EBIT24.36
EV / FCF17.67

Financial Position

Sanara MedTech Inc. maintains a current ratio of 2.58, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 611.63, indicating elevated leverage, while an interest coverage ratio of 1.81 demonstrates limited ability to service its debt obligations.

Current Ratio2.58
Quick Ratio2.24
Debt / Equity611.63
Debt / EBITDA3.68
Interest Coverage1.81

Financial Efficiency

Return on Equity (ROE)-147.73
Return on Assets (ROA)-38.13
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-84.39
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.20

Stock Price Statistics

Sanara MedTech Inc.'s stock has gained approximately 12.41852% over the past 52 weeks. The 50-day moving average sits at 34.72, while the 200-day moving average is 25.13.

Beta (5Y)N/A
52-Week Price Change12.41852%
50-Day Moving Average34.72
200-Day Moving Average25.13
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sanara MedTech Inc. generated 109.81M in revenue and converted that into -32.01M in net income, yielding earnings per share of -0.03. EBITDA reached 13.17M, while operating income came in at 10.26M.

Revenue109.81M
Gross Profit102.16M
Operating Income10.26M
Pretax Income-286,274.00
Net Income-32.01M
EBITDA13.17M
EBIT10.26M
Earnings Per Share (EPS)-0.03

Balance Sheet

Sanara MedTech Inc. holds 15.42M in cash and equivalents against 48.53M in total debt, resulting in a net debt position of 31.06M. Total book value stands at 7.94M, with working capital of 19.71M providing operational flexibility.

Cash & Cash Equivalents15.42M
Total Debt48.53M
Net Debt31.06M
Equity (Book Value)7.94M
Book Value Per Share0.86
Working Capital19.71M

Cash Flow

Sanara MedTech Inc. produced 5.69M in operating cash flow over the past twelve months. After subtracting -1.19M in capital expenditures, free cash flow totaled 4.50M - equivalent to 0.52 per share.

Operating Cash Flow5.69M
Capital Expenditures-1.19M
Free Cash Flow4.50M
FCF Per Share0.52

Margins

Sanara MedTech Inc. operates with a gross margin of 93.03, reflecting its pricing power and cost economics. The operating margin of 9.34 and net profit margin of -29.15 provide insight into operational efficiency.

Gross Margin93.03
Operating Margin9.34
Pretax Margin-0.26
Profit Margin-29.15
EBITDA Margin12.00

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.61
FCF Yield3.33

Stock Splits

Sanara MedTech Inc.'s most recent stock split took place on May 10, 2019 with a 100:1 split ratio.

Last Split Date5/10/2019
Split Ratio100:1

Scores

Sanara MedTech Inc. posts an Altman Z-Score of 3.42, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.42